Jump to content

not fake news: pfzier's wuhan vaccine may cause immune system over-reaction in some!!!!!!


socrates469bc

Recommended Posts

https://mugentech.net/index.php?/topic/9560-covid-19-vaccine-will-not-be-reserved-for-singaporeans-who-choose-to-wait-and-see/

 

 

 

 

 

 

Lucky we hold back cause Pfizer got new version of the vaccine

https://www.businessinsider.com/coronavirus-variant-south-africa-vaccines-2021-1

 

 

 

 

 

 

 

Hahahahahhahahahahhahah

 

 

 

To them it, Early bird get the worm but they forgot early worm get eaten by the bird

 

 

 

ahhahahhahahaahahahhahahaha

Edited by The_King
  • Wahaha 2
Link to comment
Share on other sites

1 hour ago, The_King said:

Pfizer has said it could update its shots to combat new variants in just six weeks

 

Ahhahahaahahahhaha

 

1 hour ago, The_King said:

So how many time you can mod your body with rdna

 

theoretically, u can mod the body as many times as u like with mrna.

 

however, the side effect is that the individual strand will over-react if not tested properly.

 

thats why the pfzier and moderna vaccines have a very much higher over-reaction rate without any verified effectiveness.

  • Like 2
Link to comment
Share on other sites

7 minutes ago, socrates469bc said:

 

 

theoretically, u can mod the body as many times as u like with mrna.

 

however, the side effect is that the individual strand will over-react if not tested properly.

 

thats why the pfzier and moderna vaccines have a very much higher over-reaction rate without any verified effectiveness.

Which mean those that take first need

Pfizer beta version 0.1

Beta version 0.2

Beta version 0.4

Beta version 0.8

Final version 1.0

Final patch update 1.01.01

Final patch update 1.02

 

Hahahahhahha 

 

If inject with so many version of vaccines I be worried

Edited by The_King
  • Wahaha 3
Link to comment
Share on other sites

1 minute ago, The_King said:

Which mean those that take first need

Pfizer beta version 0.1

Beta version 0.2

Beta version 0.4

Beta version 0.8

Final version 1.0

 

 

Hahahahhahha 

 

the untold truth is that all these wuhan vaccines r in beta testing.

 

no monkey trial no talk, ok??????

 

wahahahahhahaha

  • Wahaha 3
Link to comment
Share on other sites

finally,

 

 

SINGAPORE — Authorities have received some reports of adverse events arising from a number of people who have received the Pfizer-BioNTech COVID-19 vaccine in Singapore, said a top health official on Friday (22 January).

These reports are in the process of being compiled for submission to the COVID-19 vaccination expert panel for review and recommendations, Ministry of Health (MOH) director of medical services Kenneth Mak said during a virtual COVID-19 multi-ministry taskforce press conference.

“As soon as we're able to get those recommendations out and we have organised and categorised these adverse events, we will be then able to publicise and inform you what those adverse events are,” said Associate Professor Mak, who did not provide a figure on the number of such reports.

Prof Mak noted that in countries that have launched vaccination programmes, the majority of adverse events are very mild. These include pain, redness, swelling, soreness of the muscles after jabs were administered.

“There are some who have reported fatigue, more generalised muscle aches, and fever. Many of these symptoms, in fact, reflect the body's immune system responding to the vaccine dose that has been injected in them, he added.

“And (there) will be some that may have more serious side effects, which include allergic reactions of a variety of different grades of severity.”

In the US, allergic reactions are occurring at a rate of 11.1 per 1 million vaccinations, according to local health officials. By comparison, flu vaccines cause about 1.3 such reactions per million doses administered.

Prof Mak also spoke at length about the process for tracking such adverse events.

“This goes through the institutions which perform the vaccinations, as well as other doctors who may see patients who have had the vaccination, and have had any adverse effects,” he said.

These reports are then sent to the Health Sciences Authority (HSA), which has a pharmacovigilance programme in place to receive and process them. Such reports are reviewed by expert panels within the HSA to determine the severity of the adverse events.

Reports will also be sent to the MOH, where experts would be consulted to determine whether authorities need to tweak the list of precautions to be taken for the vaccination exercise, said Prof Mak.

He also said that authorities are “very close” to reaching a decision for a second vaccine pending the HSA’s approval, but did not specify which company would be chosen.

Currently, only the Pfizer-BioNTech COVID-19 vaccine has been approved by the HSA for pandemic use here. Two doses are required 21 days apart and it would take up to another two weeks after the second dose for those undergoing vaccination to achieve maximum protection against the virus.

The government has signed advanced purchase agreements with Moderna and Sinovac.

“We anticipate that we would have a decision made soon in our evaluation for one of the vaccines. The other vaccine, I understand, we are still clarifying further details with the company that produces the vaccine,” said Prof Mak.

“We are hopeful that if we are able to get all the information necessary for evaluation, then the HSA can complete its review process and give approval for the other vaccines as well.”

At the press conference, Health Minister and taskforce co-chair Gan Kim Yong said one scheduled Pfizer-BioNTech shipment has been delayed, and that there may be other delays to the shipments of vaccines due to Pfizer’s upgrading of its European manufacturing plant.

“We will continue to monitor our supplies closely to meet our target of vaccinating all Singaporeans and long-term residents in Singapore by the end of this year. But we will need to calibrate our roll out in tandem with our supplies,” he added.

As of Friday, more than 60,000 people in Singapore have received their first dose of the Pfizer-BioNTech vaccine, including those working in healthcare, nursing homes, frontline and essential services, and seniors in nursing homes.

Separately, 39 staff at the National Centre for Infectious Diseases (NCID) have received their second dose of the vaccine. From next Wednesday, some 5,000 to 10,000 senior residents per precinct in Ang Mo Kio and Tanjong Pagar will be able to receive the vaccine under a pilot.

 

https://sg.news.yahoo.com/adverse-events-pfizer-biontech-covid-vaccine-moh-133828162.html


 

 

https://sg.news.yahoo.com/adverse-events-pfizer-biontech-covid-vaccine-moh-133828162.html

Edited by The_King
  • Like 2
  • Wahaha 1
Link to comment
Share on other sites

32 minutes ago, The_King said:

finally,

 

 

SINGAPORE — Authorities have received some reports of adverse events arising from a number of people who have received the Pfizer-BioNTech COVID-19 vaccine in Singapore, said a top health official on Friday (22 January).

These reports are in the process of being compiled for submission to the COVID-19 vaccination expert panel for review and recommendations, Ministry of Health (MOH) director of medical services Kenneth Mak said during a virtual COVID-19 multi-ministry taskforce press conference.

“As soon as we're able to get those recommendations out and we have organised and categorised these adverse events, we will be then able to publicise and inform you what those adverse events are,” said Associate Professor Mak, who did not provide a figure on the number of such reports.

Prof Mak noted that in countries that have launched vaccination programmes, the majority of adverse events are very mild. These include pain, redness, swelling, soreness of the muscles after jabs were administered.

“There are some who have reported fatigue, more generalised muscle aches, and fever. Many of these symptoms, in fact, reflect the body's immune system responding to the vaccine dose that has been injected in them, he added.

“And (there) will be some that may have more serious side effects, which include allergic reactions of a variety of different grades of severity.”

In the US, allergic reactions are occurring at a rate of 11.1 per 1 million vaccinations, according to local health officials. By comparison, flu vaccines cause about 1.3 such reactions per million doses administered.

Prof Mak also spoke at length about the process for tracking such adverse events.

“This goes through the institutions which perform the vaccinations, as well as other doctors who may see patients who have had the vaccination, and have had any adverse effects,” he said.

These reports are then sent to the Health Sciences Authority (HSA), which has a pharmacovigilance programme in place to receive and process them. Such reports are reviewed by expert panels within the HSA to determine the severity of the adverse events.

Reports will also be sent to the MOH, where experts would be consulted to determine whether authorities need to tweak the list of precautions to be taken for the vaccination exercise, said Prof Mak.

He also said that authorities are “very close” to reaching a decision for a second vaccine pending the HSA’s approval, but did not specify which company would be chosen.

Currently, only the Pfizer-BioNTech COVID-19 vaccine has been approved by the HSA for pandemic use here. Two doses are required 21 days apart and it would take up to another two weeks after the second dose for those undergoing vaccination to achieve maximum protection against the virus.

The government has signed advanced purchase agreements with Moderna and Sinovac.

“We anticipate that we would have a decision made soon in our evaluation for one of the vaccines. The other vaccine, I understand, we are still clarifying further details with the company that produces the vaccine,” said Prof Mak.

“We are hopeful that if we are able to get all the information necessary for evaluation, then the HSA can complete its review process and give approval for the other vaccines as well.”

At the press conference, Health Minister and taskforce co-chair Gan Kim Yong said one scheduled Pfizer-BioNTech shipment has been delayed, and that there may be other delays to the shipments of vaccines due to Pfizer’s upgrading of its European manufacturing plant.

“We will continue to monitor our supplies closely to meet our target of vaccinating all Singaporeans and long-term residents in Singapore by the end of this year. But we will need to calibrate our roll out in tandem with our supplies,” he added.

As of Friday, more than 60,000 people in Singapore have received their first dose of the Pfizer-BioNTech vaccine, including those working in healthcare, nursing homes, frontline and essential services, and seniors in nursing homes.

Separately, 39 staff at the National Centre for Infectious Diseases (NCID) have received their second dose of the vaccine. From next Wednesday, some 5,000 to 10,000 senior residents per precinct in Ang Mo Kio and Tanjong Pagar will be able to receive the vaccine under a pilot.

 

https://sg.news.yahoo.com/adverse-events-pfizer-biontech-covid-vaccine-moh-133828162.html


 

 

https://sg.news.yahoo.com/adverse-events-pfizer-biontech-covid-vaccine-moh-133828162.html

 

Have commercial feat our mdc stars talking about the vaccine 

  • Like 2
  • Wahaha 1

Shalala lala la la ~ 🌠

Link to comment
Share on other sites

9 hours ago, The_King said:

Which mean those that take first need

Pfizer beta version 0.1

Beta version 0.2

Beta version 0.4

Beta version 0.8

Final version 1.0

Final patch update 1.01.01

Final patch update 1.02

 

Hahahahhahha 

 

If inject with so many version of vaccines I be worried

 

Its very similar to app S/w development!  

 

When u see The Infamous "Windows Blue screen"! U know siao liao!

 

spacer.png

  • Wahaha 3
  • Sad 1
Link to comment
Share on other sites

10 hours ago, The_King said:

finally,

 

 

SINGAPORE — Authorities have received some reports of adverse events arising from a number of people who have received the Pfizer-BioNTech COVID-19 vaccine in Singapore, said a top health official on Friday (22 January).

These reports are in the process of being compiled for submission to the COVID-19 vaccination expert panel for review and recommendations, Ministry of Health (MOH) director of medical services Kenneth Mak said during a virtual COVID-19 multi-ministry taskforce press conference.

“As soon as we're able to get those recommendations out and we have organised and categorised these adverse events, we will be then able to publicise and inform you what those adverse events are,” said Associate Professor Mak, who did not provide a figure on the number of such reports.

Prof Mak noted that in countries that have launched vaccination programmes, the majority of adverse events are very mild. These include pain, redness, swelling, soreness of the muscles after jabs were administered.

“There are some who have reported fatigue, more generalised muscle aches, and fever. Many of these symptoms, in fact, reflect the body's immune system responding to the vaccine dose that has been injected in them, he added.

“And (there) will be some that may have more serious side effects, which include allergic reactions of a variety of different grades of severity.”

In the US, allergic reactions are occurring at a rate of 11.1 per 1 million vaccinations, according to local health officials. By comparison, flu vaccines cause about 1.3 such reactions per million doses administered.

Prof Mak also spoke at length about the process for tracking such adverse events.

“This goes through the institutions which perform the vaccinations, as well as other doctors who may see patients who have had the vaccination, and have had any adverse effects,” he said.

These reports are then sent to the Health Sciences Authority (HSA), which has a pharmacovigilance programme in place to receive and process them. Such reports are reviewed by expert panels within the HSA to determine the severity of the adverse events.

Reports will also be sent to the MOH, where experts would be consulted to determine whether authorities need to tweak the list of precautions to be taken for the vaccination exercise, said Prof Mak.

He also said that authorities are “very close” to reaching a decision for a second vaccine pending the HSA’s approval, but did not specify which company would be chosen.

Currently, only the Pfizer-BioNTech COVID-19 vaccine has been approved by the HSA for pandemic use here. Two doses are required 21 days apart and it would take up to another two weeks after the second dose for those undergoing vaccination to achieve maximum protection against the virus.

The government has signed advanced purchase agreements with Moderna and Sinovac.

“We anticipate that we would have a decision made soon in our evaluation for one of the vaccines. The other vaccine, I understand, we are still clarifying further details with the company that produces the vaccine,” said Prof Mak.

“We are hopeful that if we are able to get all the information necessary for evaluation, then the HSA can complete its review process and give approval for the other vaccines as well.”

At the press conference, Health Minister and taskforce co-chair Gan Kim Yong said one scheduled Pfizer-BioNTech shipment has been delayed, and that there may be other delays to the shipments of vaccines due to Pfizer’s upgrading of its European manufacturing plant.

“We will continue to monitor our supplies closely to meet our target of vaccinating all Singaporeans and long-term residents in Singapore by the end of this year. But we will need to calibrate our roll out in tandem with our supplies,” he added.

As of Friday, more than 60,000 people in Singapore have received their first dose of the Pfizer-BioNTech vaccine, including those working in healthcare, nursing homes, frontline and essential services, and seniors in nursing homes.

Separately, 39 staff at the National Centre for Infectious Diseases (NCID) have received their second dose of the vaccine. From next Wednesday, some 5,000 to 10,000 senior residents per precinct in Ang Mo Kio and Tanjong Pagar will be able to receive the vaccine under a pilot.

 

https://sg.news.yahoo.com/adverse-events-pfizer-biontech-covid-vaccine-moh-133828162.html


 

 

https://sg.news.yahoo.com/adverse-events-pfizer-biontech-covid-vaccine-moh-133828162.html

 

8 hours ago, Chestnut said:

My kgb sis taking vaccine liao

 

alrdy said when the vaccines come out, sure will have alot of problems one.

 

@Chestnut mm can ask ur kgb sis to refer to my posting on what is vaccine effectiveness so that she can wake up her idea.

 

wahahahahhahahaha

 

 

  • Like 1
Link to comment
Share on other sites

5 minutes ago, socrates469bc said:

 

 

alrdy said when the vaccines come out, sure will have alot of problems one.

 

@Chestnut mm can ask ur kgb sis to refer to my posting on what is vaccine effectiveness so that she can wake up her idea.

 

wahahahahhahahaha

 

 

 

Bo bian. Already signed form and she under frontline also

  • Wahaha 1
  • ISWYDT 1

Shalala lala la la ~ 🌠

Link to comment
Share on other sites

1 minute ago, Chestnut said:

 

Bo bian. Already signed form and she under frontline also

 

frontline still have choice one.

 

she signed form means she alrdy indemnify the govt from blame if she kenna adverse reaction within the next 2-3yrs.

 

better pray she dont get adverse reaction. 

 

my gp loctor told me he wont ask his nurses to get the vaccination becos he also know the risks.

 

best protection is to ask them to exercise hygiene strictly.

  • Like 3
Link to comment
Share on other sites

23 hours ago, The_King said:

finally,

 

 

SINGAPORE — Authorities have received some reports of adverse events arising from a number of people who have received the Pfizer-BioNTech COVID-19 vaccine in Singapore, said a top health official on Friday (22 January).

These reports are in the process of being compiled for submission to the COVID-19 vaccination expert panel for review and recommendations, Ministry of Health (MOH) director of medical services Kenneth Mak said during a virtual COVID-19 multi-ministry taskforce press conference.

“As soon as we're able to get those recommendations out and we have organised and categorised these adverse events, we will be then able to publicise and inform you what those adverse events are,” said Associate Professor Mak, who did not provide a figure on the number of such reports.

Prof Mak noted that in countries that have launched vaccination programmes, the majority of adverse events are very mild. These include pain, redness, swelling, soreness of the muscles after jabs were administered.

“There are some who have reported fatigue, more generalised muscle aches, and fever. Many of these symptoms, in fact, reflect the body's immune system responding to the vaccine dose that has been injected in them, he added.

“And (there) will be some that may have more serious side effects, which include allergic reactions of a variety of different grades of severity.”

In the US, allergic reactions are occurring at a rate of 11.1 per 1 million vaccinations, according to local health officials. By comparison, flu vaccines cause about 1.3 such reactions per million doses administered.

Prof Mak also spoke at length about the process for tracking such adverse events.

“This goes through the institutions which perform the vaccinations, as well as other doctors who may see patients who have had the vaccination, and have had any adverse effects,” he said.

These reports are then sent to the Health Sciences Authority (HSA), which has a pharmacovigilance programme in place to receive and process them. Such reports are reviewed by expert panels within the HSA to determine the severity of the adverse events.

Reports will also be sent to the MOH, where experts would be consulted to determine whether authorities need to tweak the list of precautions to be taken for the vaccination exercise, said Prof Mak.

He also said that authorities are “very close” to reaching a decision for a second vaccine pending the HSA’s approval, but did not specify which company would be chosen.

Currently, only the Pfizer-BioNTech COVID-19 vaccine has been approved by the HSA for pandemic use here. Two doses are required 21 days apart and it would take up to another two weeks after the second dose for those undergoing vaccination to achieve maximum protection against the virus.

The government has signed advanced purchase agreements with Moderna and Sinovac.

“We anticipate that we would have a decision made soon in our evaluation for one of the vaccines. The other vaccine, I understand, we are still clarifying further details with the company that produces the vaccine,” said Prof Mak.

“We are hopeful that if we are able to get all the information necessary for evaluation, then the HSA can complete its review process and give approval for the other vaccines as well.”

At the press conference, Health Minister and taskforce co-chair Gan Kim Yong said one scheduled Pfizer-BioNTech shipment has been delayed, and that there may be other delays to the shipments of vaccines due to Pfizer’s upgrading of its European manufacturing plant.

“We will continue to monitor our supplies closely to meet our target of vaccinating all Singaporeans and long-term residents in Singapore by the end of this year. But we will need to calibrate our roll out in tandem with our supplies,” he added.

As of Friday, more than 60,000 people in Singapore have received their first dose of the Pfizer-BioNTech vaccine, including those working in healthcare, nursing homes, frontline and essential services, and seniors in nursing homes.

Separately, 39 staff at the National Centre for Infectious Diseases (NCID) have received their second dose of the vaccine. From next Wednesday, some 5,000 to 10,000 senior residents per precinct in Ang Mo Kio and Tanjong Pagar will be able to receive the vaccine under a pilot.

 

https://sg.news.yahoo.com/adverse-events-pfizer-biontech-covid-vaccine-moh-133828162.html


 

 

https://sg.news.yahoo.com/adverse-events-pfizer-biontech-covid-vaccine-moh-133828162.html

 

Quote

“And (there) will be some that may have more serious side effects, which include allergic reactions of a variety of different grades of severity.”

In the US, allergic reactions are occurring at a rate of 11.1 per 1 million vaccinations, according to local health officials. By comparison, flu vaccines cause about 1.3 such reactions per million doses administered.

 

In Singapore, more than 60,000 people have received their first dose of the Pfizer-BioNTech vaccine as of Friday, including those working in healthcare, nursing homes, frontline and essential services, and seniors in nursing homes.

 

So in USA, C19 vaccine, cuase some 111,000 people out of 1M to have severe allergic reaction!

 

Therefore, for SG case, 60,000 taken C19 vaccine.  We will ~ 6,600 people to have allergic reaction! 

 

Lets see how truthful is SG C19 Adverse Event Report!   

 

Will it be another "Not Sick No Need to Wear Mask" scholastic propaganda?   :hehe:

 

@socrates469bc  Need your statistic mind to verify what is the hypothetical values of Adverse reaction for SG?

  • Wahaha 3
Link to comment
Share on other sites

15 hours ago, Bigbird said:

 

 

So in USA, C19 vaccine, cuase some 111,000 people out of 1M to have severe allergic reaction!

 

Therefore, for SG case, 60,000 taken C19 vaccine.  We will ~ 6,600 people to have allergic reaction! 

 

Lets see how truthful is SG C19 Adverse Event Report!   

 

Will it be another "Not Sick No Need to Wear Mask" scholastic propaganda?   :hehe:

 

@socrates469bc  Need your statistic mind to verify what is the hypothetical values of Adverse reaction for SG?

 

bird, u panic until ur maths salah liao.

 

if there is 11.1 allergic reactions per million doses means there r ard 11 people who get allergic reaction after getting the vaccine shot.

 

however, due to the many reported incidents and the slow roll-out of the vaccines (which only reach 10m in bee kok recently), this is confirmed under-reporting  by the us local health officials.

 

and based on the rate given, sgp shld only have a case, not a few cases as reported by moh.

 

so, by intelligent guessing, moh and the us health authorities r not telling the truth!!!!!

 

the adverse reaction rate is much much higher than the 11.1 per million reported!!!!

 

now bird, tine to panic!!!!!

 

Less Is More: A Back-To-Basics Approach To Training

Edited by socrates469bc
  • Wahaha 1
Link to comment
Share on other sites

3 hours ago, socrates469bc said:

 

bird, u panic until ur maths salah liao.

 

if there is 11.1 allergic reactions per million doses means there r ard 11 people who get allergic reaction after getting the vaccine shot.

 

however, due to the many reported incidents and the slow roll-out of the vaccines (which only reach 10m in bee kok recently), this is confirmed under-reporting  by the us local health officials.

 

and based on the rate given, sgp shld only have a case, not a few cases as reported by moh.

 

so, by intelligent guessing, moh and the us health authorities r not telling the truth!!!!!

 

the adverse reaction rate is much much higher than the 11.1 per million reported!!!!

 

now bird, tine to panic!!!!!

 

Less Is More: A Back-To-Basics Approach To Training

 

Oh it's in absolute #, chay i assume its in % !

 

Haha...... me bad! Pai seh!

 

SO like that how?

 

spacer.png

Edited by Bigbird
  • Wahaha 1
Link to comment
Share on other sites

On 12/15/2020 at 8:39 PM, The_King said:

later like the token method, token is not compulsory but if you need token to go to mall, food center etc..... token can mean the app also, either one

 

vaccines not compulsory but if you never take then if anything happen you pay full medical fee, not allow to enter places with many ppl

 

 

From MSM. I am right. Already said on 15 Dec. 

 

Watch & listen carefully!

 

0:10 ~ 0:15

If anyone (staff) refuse to be vaccinated, staffs will be transferred. Transfer where?

 

0:56 ~ 1:13

This reporting indirectly telling public, staffs will be "sacked".

 

1:33

Future jobs require job applicants to be vaccinated.

 

 

 

 

  • Wahaha 2
Link to comment
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
×
×
  • Create New...

Important Information

Mugentech.net uses cookies to ensure you get the best experience on our website. By using this site you agree to Privacy Policy